Quantitative Data Collection Collect and pay for any associated costs for claims data from the All Payers Claim Database, or other resources as appropriate to conduct an actuarial review of the costs impacts of removing the requirement of a person to undergo step therapy or require prior authorization before a provider may prescribe or dispense a drug for the treatment of HIV. This should include data collection and analyses pre and post removal of prior authorization related to HIV treatment. Qualitative Data Collection Collect information from Colorado patients living with HIV on the cost and health impacts of removing step therapy or prior authorization requirements for access to FDA approved drugs used for the treatment or prevention of HIV and providers regarding their experience treating patients with HIV. The data collection activities shall include consultation with organizations in Colorado led by people living with HIV. Data Analysis and Research The Contractor shall evaluate the data collected to conduct an actuarial analysis of the cost and health impacts, including but not limited to premium impacts, associated with HIV utilization management using accepted actuarial best practices. Preparation of Report The Contractor shall prepare a draft report summarizing the actuarial analysis and qualitative patient/provider experience information for the Division to review. Within 20 days of receipt of comments from the Division on the draft report, the Contractor shall prepare a final report, but no later than June 30, 2026.